Indian Drug Regulator Softens Stand On Emergency Contraceptive Pills; Ad Campaigns On As Doctors Advise Caution
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Less than six months after the Drug Controller General of India clamped a ban over mass media advertisements of popular oral emergency contraceptive I-pill, the segment leader that changed hands from Cipla to Piramal Healthcare is aggressively back on national television channels with frequent time spots
You may also be interested in...
Boehringer Ingelheim Aims A Shot At India’s Booming OTC Market
The family-controlled German drug maker is preparing an entry into the Indian consumer health care segment, a market seeing a flurry of activity from its global competitors like GSK and Sanofi.
Boehringer Ingelheim Aims A Shot At India’s Booming OTC Market
The family-controlled German drug maker is preparing an entry into the Indian consumer health care segment, a market seeing a flurry of activity from its global competitors like GSK and Sanofi.
Indian Drug Regulators Closely Watch Ads On Oral Contraceptives - Is A Ban In The Offing Or Will The Doctor Decide?
MUMBAI - Controversial television advertisements on the use of emergency contraceptive pills marketed by companies like Cipla and Mankind Pharma is deepening the divide between pharmaceutical companies and Indian drug regulators